Machine learning and AI-based approaches for bioactive ligand discovery and GPCR-ligand recognition
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
In the last decade, machine learning and artificial intelligence applications have received a significant boost in performance and attention in both academic research and industry. The success behind most of the recent state-of-the-art methods can be attributed to the latest developments in deep learning. When applied to various scientific domains that are concerned with the processing of non-tabular data, for example, image or text, deep learning has been shown to outperform not only conventional machine learning but also highly specialized tools developed by domain experts. This review aims to summarize AI-based research for GPCR bioactive ligand discovery with a particular focus on the most recent achievements and research trends. To make this article accessible to a broad audience of computational scientists, we provide instructive explanations of the underlying methodology, including overviews of the most commonly used deep learning architectures and feature representations of molecular data. We highlight the latest AI-based research that has led to the successful discovery of GPCR bioactive ligands. However, an equal focus of this review is on the discussion of machine learning-based technology that has been applied to ligand discovery in general and has the potential to pave the way for successful GPCR bioactive ligand discovery in the future. This review concludes with a brief outlook highlighting the recent research trends in deep learning, such as active learning and semi-supervised learning, which have great potential for advancing bioactive ligand discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deep Residual Learning for Image Recognition
He, K., Zhang, X., Ren, S., & Sun, J. (2016) · 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR) · doi:10.1109/cvpr.2016.90 · Cited by 235,474
ImageNet classification with deep convolutional neural networks
Krizhevsky, A., Sutskever, I., & Hinton, G. E. (2017) · Communications of the ACM · doi:10.1145/3065386 · Cited by 112,155
Hochreiter, S., & Schmidhuber, J. (1997) · Neural Computation · doi:10.1162/neco.1997.9.8.1735 · Cited by 102,318
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
ImageNet: A large-scale hierarchical image database
Deng, J., Dong, W., Socher, R., Li, L.-J., Li, K., & Fei-Fei, L. (2009) · 2009 IEEE Conference on Computer Vision and Pattern Recognition · doi:10.1109/cvpr.2009.5206848 · Cited by 65,333
Gradient-based learning applied to document recognition
Lecun, Y., Bottou, L., Bengio, Y., & Haffner, P. (1998) · Proceedings of the IEEE · doi:10.1109/5.726791 · Cited by 58,805 · cited 2×
“In traditional CNN architectures, feature maps were followed by pooling layers [94,95].”
BackgroundMethodTrott, O., & Olson, A. J. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21334 · Cited by 38,412
Learning representations by back-propagating errors
Rumelhart, D. E., Hinton, G. E., & Williams, R. J. (1986) · Nature · doi:10.1038/323533a0 · Cited by 31,892
A Unified Approach to Interpreting Model Predictions
Lundberg, S., & Lee, S.-I. (2017) · arXiv · doi:10.48550/arxiv.1705.07874 · Cited by 23,707
EfficientNet: Rethinking Model Scaling for Convolutional Neural Networks
Tan, M., & Le, Q. V. (2019) · arXiv · doi:10.48550/arxiv.1905.11946 · Cited by 17,072
UniProt: a worldwide hub of protein knowledge
The UniProt Consortium (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1049 · Cited by 7,698 · cited 1×
“For each GPCR, at least two hundred known ligands were collected from the Uniprot and GLASS databases [127,128].”
MethodWeininger, D. (1988) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00057a005 · Cited by 7,436 · cited 1×
“SMILES Simplified molecular-input line-entry system (SMILES) strings are ASCII string representations of compounds (Figure 4 A), which are generated according to a procedure that guarantees a unique mapping from a SMILES string to a compound structure (though not the inverse) [120].”
MethodShuffleNet V2: Practical Guidelines for Efficient CNN Architecture Design
Ma, N., Zhang, X., Zheng, H.-T., & Sun, J. (2018) · Lecture notes in computer science · doi:10.1007/978-3-030-01264-9_8 · Cited by 7,356 · cited 1×
“For instance, DeepAtom [157] was recently designed based on ShuffleNet v2 [169], and the recentKDEEP [156] method is based on SqueezeNet [170].”
Method“Why Should I Trust You?”: Explaining the Predictions of Any Classifier
Ribeiro, M., Singh, S., & Guestrin, C. (2016) · Proceedings of the 2016 Conference of the North American Chapter of the Association for Computational Linguistics: Demonstrations · doi:10.18653/v1/n16-3020 · Cited by 6,682
SqueezeNet: AlexNet-level accuracy with 50x fewer parameters and <0.5MB model size
Iandola, F. N., Han, S., Moskewicz, M. W., Ashraf, K., Dally, W. J., & Keutzer, K. (2016) · arXiv · doi:10.48550/arxiv.1602.07360 · Cited by 6,201 · cited 1×
“For instance, DeepAtom [157] was recently designed based on ShuffleNet v2 [169], and the recentKDEEP [156] method is based on SqueezeNet [170].”
MethodBiopython: freely available python tools for computational molecular biology and bioinformatics
Cock, P. J. A., Antao, T., Chang, J. T., Chapman, B. A., Cox, C. J., Dalke, A., Friedberg, I., Hamelryck, T., Kauff, F., Wilczynski, B., et al. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp163 · Cited by 6,080 · cited 2×
“Furthermore, general-purpose libraries have been developed for the analysis of biological and structural data that lower the barrier of entry to computational biology, for example, BioPython [52] and BioPandas [53].”
BackgroundUniversal Language Model Fine-tuning for Text Classification
Howard, J., & Ruder, S. (2018) · Proceedings of the 56th Annual Meeting of the Association for Computational Linguistics (Volume 1: Long Papers) · doi:10.18653/v1/p18-1031 · Cited by 4,100 · cited 1×
“In a language model, for example, semi-supervised learning can be utilized by training a model to predict the next word in a sequence [191] or, in the context of computer vision, this could be the composition of an image into a jigsaw puzzle that the DNN learns to assemble [192].”
MethodHow to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566 · cited 1×
“6 billion US dollars, and a timeline ranging between 10–20 years, researchers have begun to favor computational methods for identifying candidate molecules for more elaborate bioactivity assays [13,14].”
BackgroundStriving for Simplicity: The All Convolutional Net
Springenberg, J. T., Dosovitskiy, A., Brox, T., & Riedmiller, M. (2014) · arXiv · doi:10.48550/arxiv.1412.6806 · Cited by 3,447
Improved protein structure prediction using potentials from deep learning
Senior, A. W., Evans, R., Jumper, J., Kirkpatrick, J., Sifre, L., Green, T., Qin, C., Žídek, A., Nelson, A. W. R., Bridgland, A., et al. (2020) · Nature · doi:10.1038/s41586-019-1923-7 · Cited by 3,378
Applications of machine learning in drug discovery and development
Vamathevan, J., Clark, D., Czodrowski, P., Dunham, I., Ferran, E., Lee, G., Li, B., Madabhushi, A., Shah, P., Spitzer, M., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0024-5 · Cited by 3,228
ZINC 15 – Ligand Discovery for Everyone
Sterling, T., & Irwin, J. J. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00559 · Cited by 3,224
MoleculeNet: a benchmark for molecular machine learning
Wu, Z., Ramsundar, B., Feinberg, E. N., Gomes, J., Geniesse, C., Pappu, A. S., Leswing, K., & Pande, V. (2018) · Chemical Science · doi:10.1039/c7sc02664a · Cited by 3,107 · cited 1×
“MoleculeNet is a large benchmark dataset consisting of more than 700,000 molecules and their property annotations [60].”
BackgroundAutomatic Chemical Design Using a Data-Driven Continuous Representation of Molecules
Gómez-Bombarelli, R., Wei, J. N., Duvenaud, D., Hernández-Lobato, J. M., Sánchez-Lengeling, B., Sheberla, D., Aguilera-Iparraguirre, J., Hirzel, T. D., Adams, R. P., & Aspuru-Guzik, A. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00572 · Cited by 3,106
Unsupervised Learning of Visual Representations by Solving Jigsaw Puzzles
Noroozi, M., & Favaro, P. (2016) · Lecture Notes in Computer Science · doi:10.1007/978-3-319-46466-4_5 · Cited by 2,775 · cited 1×
“In a language model, for example, semi-supervised learning can be utilized by training a model to predict the next word in a sequence [191] or, in the context of computer vision, this could be the composition of an image into a jigsaw puzzle that the DNN learns to assemble [192].”
MethodLearning Important Features Through Propagating Activation Differences
Shrikumar, A., Greenside, P., & Kundaje, A. (2017) · arXiv · doi:10.48550/arxiv.1704.02685 · Cited by 2,761
Convolutional Networks on Graphs for Learning Molecular Fingerprints
Duvenaud, D., Maclaurin, D., Aguilera-Iparraguirre, J., Gómez-Bombarelli, R., Hirzel, T., Aspuru-Guzik, A., & Adams, R. P. (2015) · arXiv · doi:10.48550/arxiv.1509.09292 · Cited by 2,628
Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking.
Mysinger, M. M., Carchia, M., Irwin, J. J., & Shoichet, B. K. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300687e · Cited by 2,412
Estimation of clinical trial success rates and related parameters
Wong, C. H., Siah, K. W., & Lo, A. W. (2019) · Biostatistics · doi:10.1093/biostatistics/kxx069 · Cited by 1,585
Deep learning enables rapid identification of potent DDR1 kinase inhibitors
Zhavoronkov, A., Ivanenkov, Y. A., Aliper, A., Veselov, M. S., Aladinskiy, V. A., Aladinskaya, A. V., Terentiev, V. A., Polykovskiy, D. A., Kuznetsov, M. D., Asadulaev, A., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0224-x · Cited by 1,573 · cited 2×
“6 billion US dollars, and a timeline ranging between 10–20 years, researchers have begun to favor computational methods for identifying candidate molecules for more elaborate bioactivity assays [13,14].”
BackgroundQuantum-chemical insights from deep tensor neural networks
Schütt, K. T., Arbabzadah, F., Chmiela, S., Müller, K. R., & Tkatchenko, A. (2017) · Nature Communications · doi:10.1038/ncomms13890 · Cited by 1,445 · cited 1×
“While deep learning models based on 3D voxelization methods [156,157] and graph convolutions [122,123,158] have been successful in predicting binding affinities and molecular properties from small molecule structures, representing large molecules such as membrane receptors is more computationally prohibitive.”
Deep Neural Nets as a Method for Quantitative Structure–Activity Relationships
Ma, J., Sheridan, R. P., Liaw, A., Dahl, G. E., & Svetnik, V. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/ci500747n · Cited by 1,159 · cited 1×
“MLPs can also be utilized for structure-based VS or QSAR studies as described [92].”
MethodMulti-column deep neural network for traffic sign classification
Cireşan, D., Meier, U., Masci, J., & Schmidhuber, J. (2012) · Neural Networks · doi:10.1016/j.neunet.2012.02.023 · Cited by 1,057
An Analysis of Deep Neural Network Models for Practical Applications
Canziani, A., Paszke, A., & Culurciello, E. (2016) · arXiv · doi:10.48550/arxiv.1605.07678 · Cited by 969 · cited 2×
“Modern deep learning architectures consist of hundreds of millions of parameters [42], the so-called model weights, which are learned from a training dataset using the backpropagation algorithm [43].”
BackgroundResultThe PDBbind database: methodologies and updates
Wang, R., Fang, X., Lu, Y., Yang, C.-Y., & Wang, S. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm048957q · Cited by 933 · cited 1×
“As of writing, it contains 17,679 protein–ligand complexes along with their experimentally-measured binding affinity data [171].”
BackgroundSimilarity-based virtual screening using 2D fingerprints
Willett, P. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.10.005 · Cited by 849 · cited 1×
“Fingerprint-similarity-based VS is not a new methodology [141].”
MethodLarge-scale deep unsupervised learning using graphics processors
Raina, R., Madhavan, A., & Ng, A. Y. (2009) · Proceedings of the 26th Annual International Conference on Machine Learning · doi:10.1145/1553374.1553486 · Cited by 742 · cited 1×
“These improvements include implementing machine learning models and training DNNs on GPUs [83–86], which are extremely well-suited for performing linear algebra operations such as matrix multiplications efficiently and on a large scale.”
MethodModel Evaluation, Model Selection, and Algorithm Selection in Machine Learning
Raschka, S. (2018) · arXiv · doi:10.48550/arxiv.1811.12808 · Cited by 735 · cited 1×
“selection in machine learning” [31] to learn more about the best practices.”
BackgroundSelf-citationKadurin, A., Nikolenko, S., Khrabrov, K., Aliper, A., & Zhavoronkov, A. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00346 · Cited by 587 · cited 1×
“Machine learning has already shown to be successful in various stages throughout typical ligand and drug discovery, including the discovery of novel drug targets and ligands [34,35], bioactivity prediction [36], predicting new binding sites in GPCRs [37,38], analyzing the association between the drug targets and disea…”
BackgroundLigand and Target Discovery by Fragment-Based Screening in Human Cells
Parker, C. G., Galmozzi, A., Wang, Y., Correia, B. E., Sasaki, K., Joslyn, C. M., Kim, A. S., Cavallaro, C. L., Lawrence, R. M., Johnson, S. R., et al. (2017) · Cell · doi:10.1016/j.cell.2016.12.029 · Cited by 439
Next-Generation Experimentation with Self-Driving Laboratories
Häse, F., Roch, L. M., & Aspuru-Guzik, A. (2019) · Trends in Chemistry · doi:10.1016/j.trechm.2019.02.007 · Cited by 426
De Novo Design of Bioactive Small Molecules by Artificial Intelligence
Merk, D., Friedrich, L., Grisoni, F., & Schneider, G. (2018) · Molecular Informatics · doi:10.1002/minf.201700153 · Cited by 373
Performance of machine-learning scoring functions in structure-based virtual screening.
Wójcikowski, M., Ballester, P. J., & Siedlecki, P. (2017) · Scientific Reports · doi:10.1038/srep46710 · Cited by 364
Koutsoukas, A., Monaghan, K. J., Li, X., & Huan, J. (2017) · Journal of Cheminformatics · doi:10.1186/s13321-017-0226-y · Cited by 315 · cited 3×
“[91] applied a multilayer perceptron model for diverse bioactivity prediction (pKi and pIC50) against 7 different targets, including two GPCRs, dopamine receptor D4 and cannabinoid receptor 1 based on molecular fingerprint representation of the molecules (similar to the illustration in Fig.”
BackgroundResultInfluentialChemical Proteomics Identifies Druggable Vulnerabilities in a Genetically Defined Cancer
Bar-Peled, L., Kemper, E. K., Suciu, R. M., Vinogradova, E. V., Backus, K. M., Horning, B. D., Paul, T. A., Ichu, T.-A., Svensson, R. U., Olucha, J., et al. (2017) · Cell · doi:10.1016/j.cell.2017.08.051 · Cited by 262
Li, H., Leung, K., Wong, M., & Ballester, P. J. (2015) · Molecular Informatics · doi:10.1002/minf.201400132 · Cited by 252
Using GPUs for machine learning algorithms
Steinkraus, D., Buck, I., & Simard, P. Y. (2005) · Eighth International Conference on Document Analysis and Recognition (ICDAR'05) · doi:10.1109/icdar.2005.251 · Cited by 251 · cited 1×
“These improvements include implementing machine learning models and training DNNs on GPUs [83–86], which are extremely well-suited for performing linear algebra operations such as matrix multiplications efficiently and on a large scale.”
MethodHow Chemoproteomics Can Enable Drug Discovery and Development
Moellering, R. E., & Cravatt, B. F. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.01.001 · Cited by 182
ASD v3.0: unraveling allosteric regulation with structural mechanisms and biological networks
Shen, Q., Wang, G., Li, S., Liu, X., Lu, S., Chen, Z., Song, K., Yan, J., Geng, L., Huang, Z., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv902 · Cited by 122
Spatiotemporal identification of druggable binding sites using deep learning
Kozlovskii, I., & Popov, P. (2020) · Communications Biology · doi:10.1038/s42003-020-01350-0 · Cited by 89
Multi-column Deep Neural Networks for Image Classification
Cireşan, D., Meier, U., & Schmidhuber, J. (2012) · arXiv · doi:10.48550/arxiv.1202.2745 · Cited by 53
Cited by
Raschka, S., Patterson, J., & Nolet, C. (2020) · Information · doi:10.3390/info11040193 · Cited by 703
Self-citationMolecular Dynamics Simulations in Drug Discovery and Pharmaceutical Development
Salo-Ahen, O. M. H., Alanko, I., Bhadane, R., Bonvin, A. M. J. J., Honorato, R. V., Hossain, S., Juffer, A. H., Kabedev, A., Lahtela-Kakkonen, M., Larsen, A. S., et al. (2020) · Processes · doi:10.3390/pr9010071 · Cited by 659
Generative machine learning for de novo drug discovery: A systematic review
Martinelli, D. D. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105403 · Cited by 177
Bioprocess Control: Current Progress and Future Perspectives
Rathore, A. S., Mishra, S., Nikita, S., & Priyanka, P. (2021) · Life · doi:10.3390/life11060557 · Cited by 141
Qiu, Y., Hou, Y., Gohel, D., Zhou, Y., Xu, J., Bykova, M., Yang, Y., Leverenz, J. B., Pieper, A. A., Nussinov, R., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114128 · Cited by 40
“91 In this study, we established a metabolite-specific GPCR-ML model by the following strategies: (1) implementing a metabolite-mimicking training dataset from experimentally determined ligand-GPCR pairs with high bioactive affinity (pKi [inhibition constant] ≥ 6) (Figure S23) and (2) implementing…”
Metadata
- Authors
- Raschka, S., & Kaufman, B.
- Venue
- Methods
- Publisher
- Elsevier BV
- Published
- 2020-08
- Volume
- 180
- Pages
- 89-110
- ISSN
- 1046-2023 (ISSN-L)
- OpenAlex
- W3001059052
- Cited by
- 107
- References
- 51
- FWCI
- 5.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.